PeaceHealth v sadmin berajaya

WIPO Case No. D2024-1531

ARBITRATION
AND
MEDIATION CENTER

ADMINISTRATIVE PANEL DECISION

PeaceHealth v. sadmin berajaya

Case No. D2024-1531

1. The Parties

The Complainant is PeaceHealth, United States of America (“United States” or “US”), represented by

Schwabe, Williamson & Wyatt, United States.

The Respondent is sadmin berajaya, Indonesia.

2. The Domain Name and Registrar

The disputed domain name <peacehealthlabs.com> (the “Domian Name”) is registered with NameCheap,

Inc. (the “Registrar”).

3. Procedural History

The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on April 11, 2024. On April 11, 2024, the Center transmitted by email to the Registrar a request for registrar verification in connection with the Domain Name. On April 11, 2024, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the Domain Name which differed from the named Respondent (“Doe” Respondent) and contact information in the Complaint. The Center sent an email communication to the Complainant on April 12, 2024, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant filed an amended Complaint on April 16, 2024.

The Center verified that the Complaint together with the amended Complaint satisfied the formal
requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for
Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for
Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).

In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent of the Complaint, and the proceedings commenced on April 23, 2024. In accordance with the Rules, paragraph 5, the due date for Response was May 13, 2024. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on May 21, 2024.

page 2

The Center appointed Mathias Lilleengen as the sole panelist in this matter on May 24, 2024. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required to ensure compliance with the Rules, paragraph 7.

4. Factual Background

The Complainant is a not-for-profit healthcare system with medical centers, critical access hospitals, and medical clinics located in the United States.

The Complainant owns trademarks containing the words PEACEHEALTH, such as the US trademark No.
2000247 (registered on September 10, 1996).

The Domain Name was registered on July 15, 2023. The Domain Name has resolved to a webpage purporting to offer the same services in the same states as the Complainant, and/or purporting to be connected to the Complainant. The webpage lists messages, references and contact persons which appear to be taken from the Complainant. The Respondent has also posted information on how to falsify or otherwise cheat on drug and alcohol tests.

5. Parties’ Contentions

A. Complainant

The Complainant argues that it is a well-known company in the Pacific Northwest region of the United States for its services and facilities and provides evidence of trademark registrations. It contends that the Domain Name incorporates the entirety of the Complainant’s trademark. The only difference is the addition of the term “labs” in the Domain Name. It does not prevent confusing similarity.

The Complainant argues that the Respondent has no rights or legitimate interests in respect of the Domain and/or to lure Internet users to believe the Respondent’s webpage is endorsed by the Complainant.
Name. The Complainant asserts that the Respondent has not been granted any authorization to use the

The Complainant argues that the Domain Name was registered to create a confusion with the Complainant, and/or to disrupt the business of a competitor. The Respondent attempts to disrupt the Complainant’s business by passing itself off as the Complainant. The Respondent’s use of the Complainant’s trademark - to trick consumers into believing that the Complainant endorses the Respondent and its information on how to cheat on drug and alcohol tests – is clear evidence of bad faith.

B. Respondent

The Respondent did not reply to the Complainant’s contentions.

6. Discussion and Findings

A. Identical or Confusingly Similar

The first element functions primarily as a standing requirement. The standing (or threshold) test for
confusing similarity involves a reasoned but relatively straightforward comparison between the Complainant’s
trademark and the Domain Name. WIPO Overview of WIPO Panel Views on Selected UDRP Questions,
Third Edition, (“WIPO Overview 3.0”), section 1.7.

page 3

The Complainant has established that it has rights in the trademark PEACEHEALTH. The Domain Name incorporates the Complainant’s trademark with the addition of “labs”. The addition does not prevent a finding of confusing similarity between the Domain Name and the trademark. WIPO Overview 3.0, section 1.8. When assessing identity or confusing similarity under paragraph 4(a)(i) of the Policy, the Panel may ignore the generic Top-Level Domain (“gTLD”). WIPO Overview 3.0, section 1.11.1.

The Panel finds that the Domain Name is confusingly similar to a trademark in which the Complainant has rights in accordance with paragraph 4(a)(i) of the Policy.

B. Rights or Legitimate Interests

Paragraph 4(c) of the Policy provides a list of circumstances in which a respondent may demonstrate rights
or legitimate interests in a disputed domain name. While the overall burden of proof in UDRP proceedings is
on the complainant, panels have recognized that proving a respondent lacks rights or legitimate interests in a
domain name may result in the often impossible task of “proving a negative”, requiring information that is
often primarily within the knowledge or control of the respondent. As such, where a complainant makes out a
prima facie case that the respondent lacks rights or legitimate interests, the burden of production on this
element shifts to the respondent to come forward with relevant evidence demonstrating rights or legitimate
interests in the domain name. If the respondent fails to come forward with such relevant evidence, the
complainant is deemed to have satisfied the second element. WIPO Overview 3.0, section 2.1.

Based on the evidence, the Respondent is not affiliated or related to the Complainant in any way. There is no evidence that the Respondent has registered the Domain Name as a trademark or acquired trademark rights. There is no evidence of the Respondent’s use of, or demonstrable preparations to use, the Domain Name or a name corresponding to the Domain Name in connection with a bona fide offering of goods or

services. Finally, the Panel finds that the composition of the Domain Name carries a risk of implied affiliation
with the Complainant.

The Panel finds that the Respondent has no rights or legitimate interests in respect of the Domain Name in accordance with paragraph 4(a)(ii) of the Policy.

C. Registered and Used in Bad Faith

The Panel notes that for the purposes of paragraph 4(a)(iii) of the Policy, paragraph 4(b) of the Policy establishes circumstances, in particular but without limitation, that if found by the Panel to be present, shall be evidence of the registration and use of a domain name in bad faith.

The Respondent most likely knew of the Complainant when he registered the Domain Name. It follows from the composition and use of the Domain Name. The Respondent attempts to pass itself off as the Complainant, while including information that could be detrimental to the Complainant’s reputation (e.g. information on how to falsify or otherwise cheat on drug and alcohol tests). The Respondent’s use of the Domain Name indicates fraudulent intent given the content previously available on the website. Moreover, the Respondent has not offered any explanation as to why it registered the Domain Name, nor provided any evidence of actual or contemplated good faith use of the Domain Name.

Based on the available record, the Panel finds that the Complainant has established the third element of the
Policy.

page 4

7. Decision

For the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders the Domain Name, <peacehealthlabs.com> transferred to the Complainant.

/Mathias Lilleengen/
Mathias Lilleengen
Sole Panelist
Date: May 30, 2024